We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.78B
AUM Growth
-$1.14B
Cap. Flow
-$1.45B
Cap. Flow %
-81.2%
Top 10 Hldgs %
51.86%
Holding
95
New
12
Increased
22
Reduced
11
Closed
15

Top Buys

Rank Stock Value
1
SNDK
SANDISK CORP
SNDK
+$28.4M
2
YOKU
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
+$20.2M
3
NRE
NorthStar Realty Europe Corp.
NRE
+$18.1M
4
Z icon
Zillow
Z
+$11.2M
5
MRVL icon
Marvell Technology
MRVL
+$10.6M

Top Sells

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$969M
2
ABUS icon
Arbutus Biopharma
ABUS
+$97.5M
3
EBAY icon
eBay
EBAY
+$31M
4
CALM icon
Cal-Maine
CALM
+$25.7M
5
VNET
VNET Group
VNET
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 12.55%
2 Real Estate 4.77%
3 Communication Services 3.87%
4 Technology 3.82%
5 Financials 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EJ
51
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$5.1M 0.29%
810,400
– –
SRPT icon
52
Sarepta Therapeutics
SRPT
$1.68B
$4.78M 0.27%
+123,850
New +$4.02M
GLNG icon
53
Golar LNG
GLNG
$4.99B
$4.74M 0.27%
300,283
+46,558
+18% +$1.19M
XLE icon
54
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
$4.52M 0.25%
150,000
-259,256
-63% -$8.53M
PTCT icon
55
PTC Therapeutics
PTCT
$6.29B
$3.81M 0.21%
+117,600
New +$3.46M
BLUE
56
DELISTED
bluebird bio
BLUE
$3.79M 0.21%
4,555
-4,543
-50% -$4.54M
DHT icon
57
DHT Holdings
DHT
$2.95B
$3.73M 0.21%
+460,522
New +$3.61M
AKTX
58
Akari Therapeutics
AKTX
$14.8M
$3.64M 0.2%
+330
New +$4.9M
ZX
59
DELISTED
China Zenix Auto Internatl Ltd
ZX
$3.64M 0.2%
6,074,805
– –
ASMB icon
60
Assembly Biosciences
ASMB
$513M
$3.62M 0.2%
44,583
– –
TCON
61
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$3.36M 0.19%
1,816
– –
OCRX
62
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.91M 0.16%
932,086
+179,508
+24% +$613K
BMRN icon
63
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.78M 0.16%
+26,540
New +$2.77M
PTN
64
Palatin Technologies
PTN
$13.9M
$2.32M 0.13%
3,986
– –
Z icon
65
PUT
Zillow
Z
$7.32B
$1.41M 0.08%
+60,000
New +$1.59M
SRRA
66
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.05M 0.06%
+1,750
New +$1.18M
ICPT
67
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$635K 0.04%
4,251
– –
ABUS icon
68
Arbutus Biopharma
ABUS
$871M
– –
-16,013,540
Closed -$97.5M
CALM icon
69
Cal-Maine
CALM
$4.2B
– –
-469,800
Closed -$25.7M
COF icon
70
Capital One
COF
$127B
– –
-275,000
Closed -$19.9M
EBAY icon
71
eBay
EBAY
$50.3B
– –
-1,268,210
Closed -$31M
ITB icon
72
iShares US Home Construction ETF
ITB
$2.35B
– –
-145,473
Closed -$3.8M
TVTX icon
73
Travere Therapeutics
TVTX
$5.27B
– –
-296,570
Closed -$6.01M
LL
74
DELISTED
LL Flooring Holdings, Inc.
LL
– –
-906,273
Closed -$14M
SIOX
75
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-9,375,000
Closed -$969M
1 2
3
4

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return

QVT Financial's Q4 2015 Portfolio in Review

As of Q4 2015, QVT Financial held 95 positions worth $1.78B, down 39% from $2.92B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

QVT Financial withdrew a net $1.45B in Q4 2015, closing 15 positions and reducing 11 holdings. Its most notable exit was Sio Gene Therapies Inc. Common Stock, an estimated $969M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 43% a quarter earlier, followed by Real Estate and Communication Services.

Against the trend, QVT Financial opened a new position in SANDISK CORP worth $29.5M.

  • QVT Financial's largest Q4 2015 buy was SANDISK CORP: 387,805 shares worth $29.5M.
  • QVT Financial added most to Marvell Technology in Q4 2015, an estimated $10.6M increase.
  • QVT Financial's biggest Q4 2015 reduction was VNET Group, cutting an estimated $20.2M.
  • QVT Financial fully exited Sio Gene Therapies Inc. Common Stock in Q4 2015, selling an estimated $969M.
  • QVT Financial's ten largest holdings make up 52% of its $1.78B portfolio in Q4 2015.
  • QVT Financial opened 12 new positions and closed 15 in Q4 2015.
  • QVT Financial's portfolio value fell 39% quarter-over-quarter to $1.78B.

Based on QVT Financial's 13F filing for Q4 2015, filed 16 Feb 2016.